The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
BURLINGTON, Mass., May 11, 2026 /PRNewswire/ -- SQ Innovation today announced topline results from the SUBCUT HF II trial of its product Lasix® ONYU, a novel subcutaneous formulation of furosemide for ...
Results of SUBCUT HF II, the first full-scale outcomes trial of subcutaneous furosemide for at-home treatment of edema in heart failure patients, to be released on May 9th at international heart ...
BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to ...
Please provide your email address to receive an email when new articles are posted on . scPharmaceuticals Inc. announced the FDA approved its self-administered subcutaneous furosemide injection for ...
The subcutaneous layer is the deepest skin layer. It protects a person’s body and keeps it warm. This layer also provides insulation and protection for vital tissues such as muscles, bones, and organs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results